Answers are grounded in this paper and cite their sources.
Controlled trial evaluates anti-particulate adhesion efficacy of a sunscreen in healthy females, indicating effective product performance.
This study validated a controlled in vivo test protocol using a patented particulate exposure chamber (Korean Patent No. 10-2020-0068941) to evaluate the anti-particulate adhesion efficacy of a cosmetic sunscreen formulation (SPF 50+, PA++++). The primary aim was methodological—to demonstrate that the chamber system can reliably detect differences in carbon black adhesion under standardised conditions. A split-site paired design was applied to 22 healthy adult females (mean age 60.3 ± 5.2 years; range 46–68 years). Carbon black particles (≤10 μm) were dispersed via a precision dual-stage pneumatic nozzle within a sealed chamber (22 ± 2 °C; 50 ± 5% RH). Between-group comparison was assessed by the Wilcoxon signed-rank test (primary) and the generalised estimating equation (GEE) model (complementary between-group comparison per institutional SOP). The treated site showed a 55.0% reduction in carbon black adhesion (treated: 4243 ± 2225 pixels; control: 9430 ± 4769 pixels, SE = 4.82, 95% CI: −64.4 to −45.6, Wald Z = −11.41, p < 0.001; Cohen’s d = 2.43). The Wilcoxon test confirmed the result independently (Z = −4.11, p < 0.001). All 22 subjects (100%) showed consistent reduction directionality (individual rates: 22.6–74.2%; mean 51.8%; median 52.3%). Bootstrap resampling (n = 10,000), outlier-exclusion, and exact sign test sensitivity analyses all confirmed robustness. These findings represent proof-of-concept methodological validation applied to a single product under accelerated exposure conditions.
No takes yet. Share an insight, caveat, or question.
Kwag et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: